To verify the link between the level of Top2α expression and sensitivity to CX-5461 treatment, T2AWT lymphoma cells were transduced with a modified version of RT3-REVIR doxycycline-inducible knockdown system targeting Top2α (shT2A), alongside a non-targeting (shNT) control [27,28]. Here, TOP2A is linked to lymphoma.